FORBEARANCE, RESTRUCTURING AND SETTLEMENT AGREEMENTForbearance, Restructuring and Settlement Agreement • August 16th, 2023 • Athersys, Inc / New • Pharmaceutical preparations • Delaware
This forbearance, restructuring and settlement agreement (the “Agreement”), dated as of May 17, 2023 (the “Effective Date”) by and between (i) LONZA NETHERLANDS B.V. (“LNL”) and LONZA BIOSCIENCE SINGAPORE LTD (“LBSS”; together with LNL, “Lonza“); (ii) ATHERSYS, INC. (“Athersys”); (iii) ABT HOLDING COMPANY (“ABT”); and (iv) ADVANCED BIOTHERAPEUTICS, INC. (“ABI,” and together with Athersys and ABT, the “Athersys Parties”); (iv) REGENESYS BV, REGENESYS LLC, REGENESYS EU NV, ATHERSYS GK, and ATHERSYS LTD. (collectively, the “Athersys Affiliates”) (each of Lonza and the Athersys Parties, a “Party“ and collectively the “Parties”), sets forth the terms upon which the Parties and Athersys Affiliates have agreed to settle the matters described below:
